ACROBiosystems
Specializes in GMP-grade materials, quality control kits, and various products supporting cell, gene, and antibody drug development, as well as infectious disease and autoimmune research.
Overview
ACROBiosystems provides innovative tools and solutions to address challenges from discovery to clinical applications. Their offerings include GMP-grade cell culture raw materials and CMC quality control kits, which are essential for the development of cell therapy products.
For gene therapy product development, they offer gene editing enzymes, process residual detection kits, and AAV titer detection kits. These products are designed to advance the field of gene therapy.
In the realm of antibody drug development, ACROBiosystems supplies drug target proteins, Fc receptor proteins, screening kits, and cell lines, supporting the entire workflow from research to application.
The company also supports ADC development with ADC target proteins, internalization detection reagents, Fc receptor proteins, and anti-payload antibodies, among other products and services.
For infectious disease research and vaccine development, they provide viral antigen proteins, antibodies, and test kits, facilitating advancements in these critical areas.
Additionally, ACROBiosystems offers recombinant proteins, stable cell lines, assay kits, antibodies, organoids, and a one-stop service to efficiently translate autoimmune disease therapies from research to clinical settings.